The American Journal of Managed Care

Updated GOLD Guidelines and Novel Therapeutic Approaches in the Management of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
The American Journal of Managed Care

Leveraging GOLD Guidance and Value-Based Strategies in the Management of COPD

The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
clinicaladvisor.com

2024 GOLD Report Reflects New Research and Thinking on COPD Management

Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...
Medscape

New COPD Treatments Shift Focus From Symptoms to Survival

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...
Healio

Awareness of pulmonary hypertension in patients with COPD growing

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...